Last edition
News about "Plaque Psoriasis Treatment "
Bristol Myers Squibb Secures EC Approval for Sotyktu in Psoriatic Arthritis
Bristol Myers Squibb receives European Commission (EC) approval for Sotyktu to treat active psoriatic arthritis in adults, marking the EU’s first approved TYK2 inhibitor for this indication.
Plaque Psoriasis Treatment | 12/05/2026 | By News Bureau
Takeda's Zasocitinib Shows Strong Skin Clearance in Psoriasis Study
Takeda reports Phase 3 data showing zasocitinib delivers rapid, durable skin clearance in psoriasis, with ~70 percent achieving sPGA 0/1 and early PASI 75 response, with a consistent safety profile.
Plaque Psoriasis Treatment | 30/03/2026 | By News Bureau | 147
Sun Pharma Introduces ILUMYA in India for Plaque Psoriasis Treatment
Sun Pharma has launched its global innovative drug, ILUMYA (Tildrakizumab), in India for the treatment of moderate-to-severe plaque psoriasis.
Plaque Psoriasis Treatment | 01/12/2025 | By Dineshwori | 173
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy